These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7997978)

  • 1. Parallel determination of von Willebrand factor--Ristocetin and Botrocetin cofactors.
    Thomas KB; Tune EP; Choong SC
    Thromb Res; 1994 Aug; 75(4):401-8. PubMed ID: 7997978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of von Willebrand factor activity elicited by ristocetin and botrocetin: studies on a human von Willebrand factor-binding antibody.
    Brinkhous KM; Fricke WA; Read MS
    Semin Thromb Hemost; 1985 Oct; 11(4):337-41. PubMed ID: 2416059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
    Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
    Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood group genotype and plasma von Willebrand factor in normal individuals.
    Shima M; Fujimura Y; Nishiyama T; Tsujiuchi T; Narita N; Matsui T; Titani K; Katayama M; Yamamoto F; Yoshioka A
    Vox Sang; 1995; 68(4):236-40. PubMed ID: 7660643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane.
    Howard MA; Perkin J; Salem HH; Firkin BG
    Br J Haematol; 1984 May; 57(1):25-35. PubMed ID: 6426499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Tuley EA; Mancuso DJ; Randi AM; Firkin BG; Howard MA; Sadler JE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9846-9. PubMed ID: 1409710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mutation, S1285F, within the A1 loop of von Willebrand factor induces a conformational change in A1 loop with abnormal binding to platelet GPIb and botrocetin causing type 2M von Willebrand disease.
    Stepanian A; Ribba AS; Lavergne JM; Fressinaud E; Juhan-Vague I; Mazurier C; Girma JP; Meyer D
    Br J Haematol; 2003 Feb; 120(4):643-51. PubMed ID: 12588351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
    Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
    Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y
    Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four agglutination assays evaluated for measurement of von Willebrand factor (ristocetin cofactor activity).
    Ermens AA; de Wild PJ; Vader HL; van der Graaf F
    Clin Chem; 1995 Apr; 41(4):510-4. PubMed ID: 7720238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paradoxical effect of antibody concentration on vWF-dependent platelet agglutination distinguishes between botrocetin and ristocetin-induced agglutination.
    Roberson DW; Upchurch GR; Lamb MA; Read MS; Wagner RH; Cooper HA
    Thromb Res; 1986 Dec; 44(6):749-60. PubMed ID: 3492062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-type von Willebrand disease platelet aggregating factor: a novel functional assay of von Willebrand factor.
    Takahashi H; Tatewaki W; Hanano M; Shibata A
    Thromb Res; 1987 Nov; 48(4):475-85. PubMed ID: 3127926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).
    Mohammed S; Favaloro EJ
    Methods Mol Biol; 2017; 1646():435-451. PubMed ID: 28804846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand factor.
    Read MS; Smith SV; Lamb MA; Brinkhous KM
    Blood; 1989 Aug; 74(3):1031-5. PubMed ID: 2473809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.